Literature DB >> 3143319

Pulmonary haemorrhage, pulmonary infarction, and the lupus anticoagulant.

H S Howe1, M L Boey, K Y Fong, P H Feng.   

Abstract

A patient with systemic lupus erythematosus developed pulmonary haemorrhage and pulmonary infarction as rare initial manifestations of her disease. The latter was associated with the presence of the circulating lupus anticoagulant. She recovered with pulse doses of methylprednisolone and plasmapheresis. Anticoagulants were not administered.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3143319      PMCID： PMC1003619          DOI： 10.1136/ard.47.10.869

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  18 in total

1.  Acute alveolar hemorrhage in lupus erythematosus.

Authors:  D B Gould; R Z Soriano
Journal:  Ann Intern Med       Date:  1975-12       Impact factor: 25.391

2.  The composition of pulmonary immune deposits in systemic lupus erythematosus.

Authors:  J W Eagen; J L Roberts; M M Schwartz; E J Lewis
Journal:  Clin Immunol Immunopathol       Date:  1979-02

3.  Massive pulmonary hemorrhage: fatal complication of systemic lupus erythematosus.

Authors:  S Castañeda; G Herrero-Beaumont; A Valenzuela; J Vidal; F Moldenhauer; G Renedo; P Fernández-Vallado
Journal:  J Rheumatol       Date:  1985-02       Impact factor: 4.666

4.  Systemic lupus erythematosus complicated by acute pulmonary hemorrhage: recovery following plasmapheresis and cytotoxic therapy.

Authors:  R P Millman; T B Cohen; A I Levinson; M A Kelley; M L Sachs
Journal:  J Rheumatol       Date:  1981 Nov-Dec       Impact factor: 4.666

5.  Circulating anticoagulant in systemic lupus erythematosus: clinical manifestations.

Authors:  R Pauzner; E Rosner; A Many
Journal:  Acta Haematol       Date:  1986       Impact factor: 2.195

6.  Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.

Authors:  M L Boey; C B Colaco; A E Gharavi; K B Elkon; S Loizou; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

7.  Severe, acute pulmonary disease in patients with systemic lupus erythematosus: ten years of experience at the National Institutes of Health.

Authors:  S Carette; A M Macher; A Nussbaum; P H Plotz
Journal:  Semin Arthritis Rheum       Date:  1984-08       Impact factor: 5.532

Review 8.  Pulmonary hemorrhage in systemic lupus erythematosus.

Authors:  J W Eagen; V A Memoli; J L Roberts; G R Matthew; M M Schwartz; E J Lewis
Journal:  Medicine (Baltimore)       Date:  1978-11       Impact factor: 1.889

Review 9.  Alveolar hemorrhage syndromes: diffuse microvascular lung hemorrhage in immune and idiopathic disorders.

Authors:  J W Leatherman; S F Davies; J R Hoidal
Journal:  Medicine (Baltimore)       Date:  1984-11       Impact factor: 1.889

10.  Pulmonary hemorrhage and immune-complex deposition in the lung. Complications in a patient with systemic lupus erythematosus.

Authors:  A Churg; W Franklin; K L Chan; E Kopp; C B Carrington
Journal:  Arch Pathol Lab Med       Date:  1980-07       Impact factor: 5.534
View more
  4 in total

Review 1.  The lung in the antiphospholipid syndrome.

Authors:  G Espinosa; R Cervera; J Font; R A Asherson
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

2.  Pulmonary hemorrhage in children with glomerulonephritis.

Authors:  V M Reznik; W R Griswold; J M Lemire; S A Mendoza
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

3.  Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survival.

Authors:  Nayef M Kazzaz; Patrick Coit; Emily E Lewis; W Joseph McCune; Amr H Sawalha; Jason S Knight
Journal:  Lupus Sci Med       Date:  2015-09-23

Review 4.  Unusual manifestations of the antiphospholipid syndrome.

Authors:  Ronald A Asherson; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.